6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: Correlation with vesicular monoamine transporter expression

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 6, 2010, Pages 2800-2810

  Fottner, Christian ^a   Helisch, A ^a   Anlauf, M ^b   Rossmann, H ^a   Musholt, T J ^a   Kreft, A ^a   Schadmand Fischer, S ^a   Bartenstein, P ^c   Lackner, K J ^a   Kloppel G ^d   Schreckenberger, M ^a   Weber, M M ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; FLUORODIHYDROXYPHENYLALANINE F 18; METADRENALIN; NORADRENALIN; SUCCINATE DEHYDROGENASE; UNCLASSIFIED DRUG; VESICULAR MONOAMINE TRANSPORTER; VON HIPPEL LINDAU PROTEIN; (3 IODOBENZYL)GUANIDINE; 6 FLUORODOPA F 18; BIOLOGICAL MARKER; DIAGNOSTIC AGENT; DOPA; DRUG DERIVATIVE; RADIOPHARMACEUTICAL AGENT;

ADRENAL INCIDENTALOMA; ADULT; ARTICLE; BIOCHEMISTRY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GENETIC DISORDER; HUMAN; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MALE; MOLECULAR GENETICS; MULTIPLE ENDOCRINE NEOPLASIA; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAGANGLIOMA; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY; ADOLESCENT; ADRENAL TUMOR; AGED; BIOSYNTHESIS; COMPARATIVE STUDY; GENETIC MARKER; GENETICS; METABOLISM; MIDDLE AGED; SCINTISCANNING; STATISTICAL ANALYSIS;

3-IODOBENZYLGUANIDINE; ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; AGED; BIOLOGICAL MARKERS; DATA INTERPRETATION, STATISTICAL; DIHYDROXYPHENYLALANINE; FEMALE; GENETIC MARKERS; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARAGANGLIOMA; PHEOCHROMOCYTOMA; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED; VESICULAR MONOAMINE TRANSPORT PROTEINS; YOUNG ADULT;

EID: 77954462618     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-2352     Document Type: Article

References (33)

1. Lenders JW, Eisenhofer G, Mannelli M, Pacak K 2005 Phaeochromocytoma. Lancet 366:665-675
2. Havekes B, Pacak K 2008 Pheochromocytoma. Nat Clin Pract Cardiovasc Med 5:E1
3. Neumann HP, Eng C 2009 The approach to the patient with paraganglioma J Clin Endocrinol Metab 94:2677-2683
4. Karagiannis A, Mikhailidis DP, Athyros VG, Harsoulis F 2007 Pheochromocytoma: an update on genetics and management. Endocr Relat Cancer 14:935-956
5. Erlic Z, Neumann HP 2009 Diagnosing patients with hereditary paraganglial tumours. Lancet Oncol 10:741
6. Pacak K, Eisenhofer G, Ahlman H, Bornstein SR, Gimenez-Roqueplo AP, Grossman AB, Kimura N, Mannelli M, McNicol AM, Tischler AS; International Symposium on Pheochromocytoma 2007 Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nat Clin Pract Endocrinol Metab 3:92-102
7. Havekes B, Lai EW, Corssmit EP, Romijn JA, Timmers HJ, Pacak K 2008 Detection and treatment of pheochromocytomas and paragangliomas: current standing of MIBG scintigraphy and future role of PET imaging. Q J Nucl Med Mol Imaging 52:419-429
8. Vaidyanathan G 2008 Meta-iodobenzylguanidine and analogues: chemistry and biology. Q J Nucl Med Mol Imaging 52:351-368
9. Uccella S, Cerutti R, Vigetti D, Furlan D, Oldrini R, Carnevali I, Pelosi G, La Rosa S, Passi A, Capella C 2006 Histidine decarboxylase, DOPA decarboxylase, and vesicular monoamine transporter 2 expression in neuroendocrine tumors: immunohistochemical study and gene expression analysis. J Histochem Cytochem 54:863-875
10. Wiseman GA, Pacak K, O'Dorisio MS, Neumann DR, Waxman AD, Mankoff DA, Heiba SI, Serafini AN, Tumeh SS, Khutoryansky N, Jacobson AF 2009 Usefulness of 123I-MIBG scintigraphy in the evaluation of patients with known or suspected primary or metastatic pheochromocytoma or paraganglioma: results from a prospective multicentre trial. J Nucl Med 50:1448-1454
11. Timmers HJ, Eisenhofer G, Carrasquillo JA, Chen CC, Whatley M, Ling A, Adams KT, Pacak K 2009 Use of 6-[18F]-fluorodopamine positron emission tomography (PET) as first-line investigation for the diagnosis and localization of non-metastatic and metastatic phaeochromocytoma (PHEO). Clin Endocrinol (Oxf) 71:11-17
12. Pacak K, Eisenhofer G, Goldstein DS 2004 Functional imaging of endocrine tumors: role of positron emission tomography. Endocr Rev 25:568-580
13. Brink I, Hoegerle S, Klisch J, Bley TA 2005 Imaging of pheochromocytoma and paraganglioma. Fam Cancer 4:61-68
14. Ilias I, Sahdev A, Reznek RH, Grossman AB, Pacak K 2007 The optimal imaging of adrenal tumours: a comparison of different methods. Endocr Relat Cancer 14:587-599 (Pubitemid 350074049)
15. Havekes B, King K, Lai EW, Romijn JA, Corssmit EP, Pacak K 2010 New imaging approaches to phaeochromocytomas and paragangliomas. Clin Endocrinol (Oxf) 72:137-145
16. Jager PL, Chirakal R, Marriott CJ, Brouwers AH, Koopmans KP, Gulenchyn KY 2008 6-L-18F-fluorodihydroxyphenylalanine PET in neuroendocrine tumors: basic aspects and emerging clinical applications. J Nucl Med 49:573-586
17. Hoegerle S, Nitzsche E, Altehoefer C, Ghanem N, Manz T, Brink I, Reincke M, Moser E, Neumann HP 2002 Pheochromocytomas: detection with 18FDOPA whole body PET - initial results. Radiology 222:507-512
18. Hoegerle S, Ghanem N, Altehoefer C, Schipper J, Brink I, Moser E, Neumann HP 2003 18F-DOPA positron emission tomography for the detection of glomus tumours. Eur J Nucl Med Mol Imaging 30:689-694
19. 111in-pentetreotide scintigraphy in localization of nonmetastatic and metastatic pheochromocytoma. J Nucl Med 49:1613-1619
20. Ilias I, Yu J, Carrasquillo JA, Chen CC, Eisenhofer G, Whatley M, McElroy B, Pacak K 2003 Superiority of 6-[18F]-fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma. J Clin Endocrinol Metab 88:4083-4087
21. Taïeb D, Tessonnier L, Sebag F, Niccoli-Sire P, Morange I, Colavolpe C, De Micco C, Barlier A, Palazzo FF, Henry JF, Mundler O 2008 The role of 18F-FDOPA and 18F-FDG-PET in the management of malignant and multifocal phaeochromocytomas. Clin Endocrinol (Oxf) 69:580-586
22. Kaji P, Carrasquillo JA, Linehan WM, Chen CC, Eisenhofer G, Pinto PA, Lai EW, Pacak K 2007 The role of 6-[18F] fluorodopamine positron emission tomography in the localization of adrenal pheochromocytoma associated with von Hippel-Lindau syndrome. Eur J Endocrinol 156:483-487
23. Fiebrich HB, Brouwers AH, Kerstens MN, Pijl ME, Kema IP, de Jong JR, Jager PL, Elsinga PH, Dierckx RA, van der Wal JE, Sluiter WJ, de Vries EG, Links TP 2009 18F-DOPA PET is superior to conventional imaging with 123I-metaiodobenzylguanidine scintigraphy, CT, and MRI in localizing tumors causing catecholamine excess. J Clin Endocrinol Metab 94:3922-3930
24. Anlauf M, Eissele R, Schäfer MK, Eiden LE, Arnold R, Pauser U, Klöppel G, Weihe E 2003 Expression of the vesicular monoamine transporter (VMAT1 and VMAT2) in the endocrine pancreas and pancreatic endocrine tumors. J Histochem Cytochem 51:1027-1040 (Pubitemid 36919980)
25. Koopmans KP, Neels OC, Kema IP, Elsinga PH, Sluiter WJ, Vanghillewe K, Brouwers AH, Jager PL, de Vries EG 2008 Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography. J Clin Oncol 26:1489-1495
26. Schuldiner S, Shirvan A, Linial M 1995 Vesicular neurotransmitter transporters: from bacteria to humans. Physiol Rev 75:369-392
27. Weihe E, Eiden LE 2000 Chemical neuroanatomy of the vesicular amine transporters. FASEB J 14:2435-2449
28. Peter D, Jimenez J, Liu Y, Kim J, Edwards RH 1994 The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors. J Biol Chem 11; 269:7231-7237 (Pubitemid 24217912)
29. Erickson JD, Schafer MK, Bonner TI, Eiden LE, Weihe E 1996 Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. Proc Natl Acad Sci USA 93:5166-5171
30. Peter D, Liu Y, Sternini C, de Giorgio R, Brecha N, Edwards RH 1995 Differential expression of two vesicular monoamine transporters. J Neurosci 15:6179-6188
31. Huynh TT, Pacak K, Brouwers FM, Abu-Asab MS, Worrell RA, Walther MM, Elkahloun AG, Goldstein DS, Cleary S, Eisenhofer G 2005 Different expression of catecholamine transporters in phaeochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2. Eur J Endocrinol 153:551-563
32. Tischler AS 2008 Pheochromocytoma and extra-adrenal paraganglioma: updates. Arch Pathol Lab Med 132:1272-1284
33. Tischler AS, Kimura N, Mcnicol AM 2006 Pathology of pheochromocytoma and extra-adrenal paraganglioma. Ann NY Acad Sci 1073:557-570